BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21778301)

  • 1. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
    Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
    Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
    Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
    Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer.
    van de Pol JAA; van den Brandt PA; van Engeland M; Godschalk RWL; van Schooten FJ; Hogervorst JGF; Schouten LJ
    Sci Rep; 2020 Jan; 10(1):137. PubMed ID: 31924838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the VHL polymorphisms rs779805 and rs1642742 affect renal cell carcinoma susceptibility, prognosis and survival in Central European population?
    Chrabańska M; Szweda-Gandor N; Drozdzowska B
    Medicine (Baltimore); 2023 Dec; 102(50):e36540. PubMed ID: 38115281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.
    Lessi F; Mazzanti CM; Tomei S; Di Cristofano C; Minervini A; Menicagli M; Apollo A; Masieri L; Collecchi P; Minervini R; Carini M; Bevilacqua G
    Med Oncol; 2014 Mar; 31(3):840. PubMed ID: 24446253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
    Lv C; Bai Z; Liu Z; Luo P; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5781-6. PubMed ID: 26191297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
    Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
    Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk.
    Wei H; Ke HL; Lin J; Shete S; Wood CG; Hildebrandt MA
    Mol Carcinog; 2014 Jan; 53(1):1-7. PubMed ID: 22517515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
    Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
    Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence-associated protein p400 is a prognostic marker in renal cell carcinoma.
    Macher-Goeppinger S; Bermejo JL; Schirmacher P; Pahernik S; Hohenfellner M; Roth W
    Oncol Rep; 2013 Nov; 30(5):2245-53. PubMed ID: 23982490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
    Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
    J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.
    Yao M; Yoshida M; Kishida T; Nakaigawa N; Baba M; Kobayashi K; Miura T; Moriyama M; Nagashima Y; Nakatani Y; Kubota Y; Kondo K
    J Natl Cancer Inst; 2002 Oct; 94(20):1569-75. PubMed ID: 12381710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
    Moore LE; Nickerson ML; Brennan P; Toro JR; Jaeger E; Rinsky J; Han SS; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Schmidt LS; Lenz P; Karami S; Linehan WM; Merino M; Chanock S; Boffetta P; Chow WH; Waldman FM; Rothman N
    PLoS Genet; 2011 Oct; 7(10):e1002312. PubMed ID: 22022277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
    Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
    Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
    Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
    Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment.
    Wierzbicki PM; Klacz J; Kotulak-Chrzaszcz A; Wronska A; Stanislawowski M; Rybarczyk A; Ludziejewska A; Kmiec Z; Matuszewski M
    Int J Oncol; 2019 Aug; 55(2):371-390. PubMed ID: 31268155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma.
    Chrabańska M; Szweda-Gandor N; Drozdzowska B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.